Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.25 USD | +2.50% | +15.22% | +66.45% |
04-01 | Solid Biosciences' SGT-003 Receives US FDA's Rare Pediatric Disease Label | MT |
04-01 | Solid Biosciences Gets FDA Rare-Pediatric Designation for SGT-003 in Duchenne | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+66.45% | 379M | |
+9.82% | 106B | |
+0.99% | 104B | |
+6.72% | 23.25B | |
-13.78% | 22.5B | |
-6.64% | 18.7B | |
-37.26% | 17.95B | |
-10.79% | 16.99B | |
+8.20% | 14.26B | |
+39.15% | 12.76B |
- Stock Market
- Equities
- SLDB Stock
- News Solid Biosciences Inc.
- Solid Biosciences : Credit Suisse Upgrades Solid Biosciences to Neutral from Underperform, Adjusts Price Target to $7 from $2